Because the diagnosis and treatment of community-acquired pneumonia (CAP) continue to
present decision-making challenges, a number of professional organizations have …

The Infectious Diseases Society of America (IDSA) has published guidelines for the
treatment of community-acquired pneumonia (CAP). Although Streptococcus pneumoniae …

Lower respiratory tract infections are the major cause of death due to infectious disease in
the developed and developing world. Despite substantial progress in defining pathogens …

Community-acquired pneumonia (CAP) is a common and potentially serious illness with
significant human and economic costs to society. The recent collaborative statement from …

The management of respiratory tract infections is a complex process. Concern over
increasing levels of bacterial resistance and the inappropriate use of antibiotics has led to …

Community-acquired pneumonia (CAP) is a costly disease that is associated with significant
morbidity and mortality. The growing prevalence of this disease has resulted in various …

Community-Acquired Pneumonia (CAP) refers to pneumonia acquired outside of hospitals
or extended-care facilities, and is distinct from Nosocomial or hospital-acquired pneumonia …

Community-acquired pneumonia (CAP) is a common illness, with the majority of patients
treated out of the hospital, yet the greatest burden of the cost of care comes from inpatient …

Background: This document provides evidence-based clinical practice guidelines on the
management of adult patients with community-acquired pneumonia. Methods: A …

Community-acquired pneumonia (CAP) is common, costly, and clinically serious. Several
national and international practice guidelines have been developed to promote more …